Stock PRLD PRELUDE THERAPEUTICS INCORPORATED
Add to a list
To use this feature you must be a member
Log inSign up

News Chart Prelude Therapeutics Incorporated

Equities

PRLD

US74065P1012

Delayed Nasdaq
Other stock markets
 16:00:00 2024-05-14 EDT 		5-day change 1st Jan Change
3.86 USD +1.58% Intraday chart for Prelude Therapeutics Incorporated +4.32% -9.60%
05-07 Prelude Therapeutics Incorporated Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
04-10 Bryant D. Lim to Serve as Principal Financial Officer and Principal Accounting Officer of Prelude Therapeutics Incorporated CI
4e224149a6c.SjB1dpKt4Lh8AuQ9VCrEPMMFFvActVd5rei0IBRZpgM.HlosNerb1PJIUdJwLXOMWLk1Vb9z4SRB16OCSyAW6Gp4WCM96sSuyjt63A~d21057224dc797b0902ffae79675d8bc
  1. Stock Market
  2. Equities
  3. PRLD Stock
  4. Charts Prelude Therapeutics Incorporated
  5. News Chart
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW